ASHAP salvage therapy for recurrent and refractory Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).

被引：0
|
作者：
Hanel, M
Hoffknecht, MM
Peters, SO
Fiedler, F
Hanel, A
Kruger, WH
Zeller, W
Braumann, D
Illiger, HJ
Metzner, B
Schubert, JC
Schmitz, N
Weh, HJ
Kroger, N
Zander, AR
机构：
[1] KUCHWALDKRANKENHAUS,CLIN INTERNAL MED 3,DEPT HEMATOL,CHEMNITZ,GERMANY
[2] UNIV HAMBURG,HOSP EPPENDORF,BMT CTR,D-20246 HAMBURG,GERMANY
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4559 / 4559
页数：1
相关论文
共 50 条
  • [31] MAGE-A4 expression in Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL).
    Skinnider, BF
    Jungbluth, AA
    Banerjee, D
    Gascoyne, RD
    LABORATORY INVESTIGATION, 2001, 81 (01) : 179A - 179A
  • [32] Therapy of non-Hodgkin's lymphoma
    Coffey, J.
    Hodgson, D. C.
    Gospodarowicz, M. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (Suppl 1) : S28 - S36
  • [33] Hodgkin's and Non-Hodgkin's Lymphoma
    Manning, Jaye
    CANCER FORUM, 2007, 31 (02) : 117 - 117
  • [34] High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma
    Wang, WS
    Tzeng, CH
    Chiou, TJ
    Liu, JH
    Hsieh, RK
    Yen, CC
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 154 - 157
  • [35] Therapy of non-Hodgkin's lymphoma
    J. Coffey
    D. C. Hodgson
    M. K. Gospodarowicz
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : S28 - S36
  • [36] Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma
    中华医学杂志(英文版), 2010, (22) : 3206 - 3211
  • [37] Ligustrazine as a salvage agent for patients with relapsed or refractory non-Hodgkin's lymphoma
    Yang Xi-gui
    Jiang Chao
    CHINESE MEDICAL JOURNAL, 2010, 123 (22) : 3206 - 3211
  • [38] Recurrent non-Hodgkin's lymphoma of the appendix
    Katz, DS
    Stein, LB
    Mazzie, JP
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) : 1443 - 1445
  • [39] ASHAP+/-ABMT: An effective strategy for relapsing and refractory Hodgkin's disease (HD).
    Velasquez, WS
    Pereira, AR
    Dunphy, F
    Broun, GO
    Petruska, PJ
    Broun, ER
    BLOOD, 1995, 86 (10) : 3289 - 3289
  • [40] FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
    Child, JA
    Johnson, SA
    Rule, S
    Smith, GM
    Morgan, GJ
    Johnson, PWM
    Prentice, AG
    Tollerfield, SM
    Wareham, E
    LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 309 - 317
12345